Piriformis Syndrome Market: Global Industry Analysis and Forecast (2022-2027) by Cause, Diagnostic Test, Treatment, Distribution Channel, End-User, and Region

Piriformis Syndrome Market size was valued at US$ 232.64 Mn. in 2021 and the total revenue is expected to grow at a CAGR of 6.0% through 2022 to 2027, reaching nearly US$ 330 Mn.

Piriformis Syndrome Market Overview:

Piriformis syndrome is a disorder in which the piriformis muscle in the buttocks spasms, causing pain in the buttocks. The neighbouring sciatic nerve can be irritated by the piriformis muscle, causing discomfort, numbness, and tingling down the back of the leg and into the foot (similar to sciatic pain). The pain associated with piriformis syndrome tends to intensify after prolonged sitting or physical activity such as walking. The majority of piriformis syndrome patients feel better after lying on their backs. Global Piriformis Syndrome Market To know about the Research Methodology :- Request Free Sample Report

Piriformis Syndrome Market Dynamics:

Piriformis syndrome is a severe neuromuscular disorder caused by compression of the sciatic nerve by the piriformis muscle. The piriformis muscle is a flat, band-like muscle found in the top part of the hip joint in the buttock. Piriformis syndrome is most common in adults and can affect people of all ages and levels of activity. Trauma, spasms, and overuse damage are the most prevalent causes of piriformis syndrome. The piriformis syndrome is also more common in patients with lower back discomfort, according to the National Center for Biotechnology Information (NCBI). Stretching the piriformis muscle many times a day, particularly when paired with hamstring exercises, will avoid lower back tightness and release tension from hip to foot. The rising incidence of piriformis syndrome, more screening, rising safety and success of medication therapies, and the growing senior population are all driving the piriformis syndrome market. The complications of procedures, as well as a lack of information regarding the disease, are among the market limitations. Furthermore, difficulties in diagnosing the illness among the patient population is expected to limit the Piriformis Syndrome market growth during the forecast period.

Piriformis Syndrome Market Segment Analysis:

Based on the Cause, the market is segmented into Trauma, Spasms, Overuse injury, and others. Trauma segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2022-2027. A history of trauma, either a direct buttock contusion or a hip/lower back torsional injury, is found in around half of patients with piriformis syndrome. Because the remaining 50% of cases are of spontaneous onset, the treating physician must have a high index of suspicion. Spasms segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2022-2027. A spasm is an involuntary contraction of a muscle, a set of muscles, or a hollow organ, such as the bladder, that occurs suddenly. Many medical diseases, including dystonia, can induce spasmodic muscular contractions. The most typical symptom is a muscular cramp accompanied by a sharp flash of pain. The most prevalent reasons are overexertion, dehydration, and stress. Spasms occur when a muscle moves suddenly and uncontrollably. Muscle spasms can be as minor as a twitch or as severe as a painful cramp, and they can affect muscles in any part of the body. Muscle spasms can be relieved by stretching and gently massaging the affected area. Applying heat to the area with a warm towel, heating pad, or hot water in the shower may also be beneficial. Global Piriformis Syndrome Market Based on the Treatment, the market is segmented into Medication, NSAIDS, Naproxen, Ibuprofen, Piriformis Muscle Injection, Botox Injection, Steroid Injection, Physical Therapy, Acupuncture, Prolotherapy, Osteopathic Manipulative Treatment (OMT), Surgery, and Others. Medication segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2022-2027. Ibuprofen and other over-the-counter anti-inflammatory drugs can help reduce swelling and pain. Your doctor may inject straight into the piriformis muscle in some circumstances. The spasm and pain can be relieved with a topical anaesthetic and corticosteroid. Physical Therapy segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2022-2027. Following a piriformis syndrome diagnosis, the patient should be advised to refrain from the offending activities and begin physical therapy treatment. When combined with stretching and manual therapy, physical therapy modalities are frequently useful types of treatment. Based on the End-User, the market is segmented into Hospitals & Clinics, Diagnostic Centers, and Others. Hospitals & Clinics segment is expected to hold the largest market shares of xx% by 2027. This is due to the growing number of the piriformis syndrome patients increases the number of treatments of piriformis syndrome in the hospitals & clinics. This is the key driver that is expected to drives the growth of this segment in the market during the forecast period.

Piriformis Syndrome Market Regional Insights:

North America region is expected to dominate the Piriformis Syndrome market during the forecast period 2022-2027. North America region is expected to hold the largest market shares of xx% by 2027. Because of its well-established healthcare system, rising healthcare expenditures, growing awareness of the syndrome, and growing senior population, the North American region is expected to dominate the market. Furthermore, the North America market growth is driven by a significant concentration of prominent hospitals in this region's developed countries, as well as favourable reimbursement rates. Also, a big number of well-known firms in the United States are expected to contribute to the piriformis syndrome market's faster growth in this region. Europe region is expected to grow rapidly at a CAGR of xx% during the forecast period 2022-2027. The market is expected to be driven by government assistance for research and development expenditures, as well as an increase in secondary lifestyle in the Europe region. Furthermore, countries such as Germany and France are leading the market growth in Europe. Global Piriformis Syndrome Market The objective of the report is to present a comprehensive analysis of the Global Piriformis Syndrome Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also help in understanding the Global Piriformis Syndrome Market dynamic, structure by analyzing the market segments and project the Global Piriformis Syndrome Market size. Clear representation of competitive analysis of key players by Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Piriformis Syndrome Market make the report investor’s guide.

Piriformis Syndrome Market Scope: Inquire before buying

Global Piriformis Syndrome Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2027
Historical Data: 2017 to 2021 Market Size in 2021: US $ 232.64 Mn.
Forecast Period 2022 to 2027 CAGR: 6.0% Market Size in 2027: US $ 330 Mn.
Segments Covered: by Cause • Trauma • Spasms • Overuse injury • Others
by Diagnostic Test • Magnetic Resonance Imaging (MRI) • Computed Tomography (CT) • X-rays • Neurophysiologic Testing • Electromyography (EMG) • Beatty Test • FAIR (Flexion, adduction, and Internal Rotation) Test • Others
by Treatment • Medication • NSAIDS • Naproxen • Ibuprofen • Piriformis Muscle Injection • Botox Injection • Steroid Injection • Physical Therapy • Acupuncture • Prolotherapy • Osteopathic Manipulative Treatment (OMT) • Surgery • Others
by Distribution Channel • E-Commerce • Retail Pharmacies • Others
by End-User • Hospitals & Clinics • Diagnostic Centers • Others

Piriformis Syndrome Market, by Region

• North America • Europe • Asia Pacific • South America • Middle East and Africa

Piriformis Syndrome Market Key Players

Bayer AG • Novartis AG • AstraZeneca • Endo Pharmaceuticals • Teva Pharmaceuticals • Omron Healthcare • Sanofi S.A. • DePuy Synthes Companies • Miracle Stretch, LLC • Flex Pharma, Inc. • Nidd valley medical • SEIRIN Corporation • Others Frequently Asked Questions: 1] Which region is expected to hold the highest share in the Piriformis Syndrome Market? Ans. North America is expected to hold the highest share in the Piriformis Syndrome Market. 2] Who are the top key players in the Piriformis Syndrome Market? Ans. Bayer AG, Novartis AG, AstraZeneca, Endo Pharmaceuticals, Teva Pharmaceuticals, and Omron Healthcare are the top key players in the Piriformis Syndrome Market. 3] Which segment holds the largest market share in the Piriformis Syndrome market by 2027? Ans. Hospitals & Clinics segment hold the largest market share in the Piriformis Syndrome market by 2027. 4] What is the market size of the Piriformis Syndrome market by 2027? Ans. The market size of the Piriformis Syndrome market is expected to reach US $330 Mn. by 2027. 5] What was the market size of the Piriformis Syndrome market in 2021? Ans. The market size of the Piriformis Syndrome market was worth US $232.64 Mn. in 2021.
1. Global Piriformis Syndrome Market: Research Methodology 2. Global Piriformis Syndrome Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Piriformis Syndrome Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Global Piriformis Syndrome Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. Global Piriformis Syndrome Market Segmentation 4.1 Global Piriformis Syndrome Market, by Cause (2022-2027) • Trauma • Spasms • Overuse injury • Others 4.2 Global Piriformis Syndrome Market, by Diagnostic Test (2022-2027) • Magnetic Resonance Imaging (MRI) • Computed Tomography (CT) • X-rays • Neurophysiologic Testing • Electromyography (EMG) • Beatty Test • FAIR (Flexion, adduction, and Internal Rotation) Test • Others 4.3 Global Piriformis Syndrome Market, by Treatment (2022-2027) • Medication • NSAIDS • Naproxen • Ibuprofen • Piriformis Muscle Injection • Botox Injection • Steroid Injection • Physical Therapy • Acupuncture • Prolotherapy • Osteopathic Manipulative Treatment (OMT) • Surgery • Others 4.4 Global Piriformis Syndrome Market, by Distribution Channel (2022-2027) • E-Commerce • Retail Pharmacies • Others 4.5 Global Piriformis Syndrome Market, by End-User (2022-2027) • Hospitals & Clinics • Diagnostic Centers • Others 5. North America Piriformis Syndrome Market (2022-2027) 5.1 Global Piriformis Syndrome Market, by Cause (2022-2027) • Trauma • Spasms • Overuse injury • Others 5.2 Global Piriformis Syndrome Market, by Diagnostic Test (2022-2027) • Magnetic Resonance Imaging (MRI) • Computed Tomography (CT) • X-rays • Neurophysiologic Testing • Electromyography (EMG) • Beatty Test • FAIR (Flexion, adduction, and Internal Rotation) Test • Others 5.3 Global Piriformis Syndrome Market, by Treatment (2022-2027) • Medication • NSAIDS • Naproxen • Ibuprofen • Piriformis Muscle Injection • Botox Injection • Steroid Injection • Physical Therapy • Acupuncture • Prolotherapy • Osteopathic Manipulative Treatment (OMT) • Surgery • Others 5.4 Global Piriformis Syndrome Market, by Distribution Channel (2022-2027) • E-Commerce • Retail Pharmacies • Others 5.5 Global Piriformis Syndrome Market, by End-User (2022-2027) • Hospitals & Clinics • Diagnostic Centers • Others 5.6 North America Piriformis Syndrome Market, by Country (2022-2027) • United States • Canada • Mexico 6. Asia Pacific Piriformis Syndrome Market (2022-2027) 6.1. Asia Pacific Piriformis Syndrome Market, by Cause (2022-2027) 6.2. Asia Pacific Piriformis Syndrome Market, by Diagnostic Test (2022-2027) 6.3. Asia Pacific Piriformis Syndrome Market, by Treatment (2022-2027) 6.4. Asia Pacific Piriformis Syndrome Market, by Distribution Channel (2022-2027) 6.5. Asia Pacific Piriformis Syndrome Market, by End-User (2022-2027) 6.6. Asia Pacific Piriformis Syndrome Market, by Country (2022-2027) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Middle East and Africa Piriformis Syndrome Market (2022-2027) 7.1 Middle East and Africa Piriformis Syndrome Market, by Cause (2022-2027) 7.2. Middle East and Africa Piriformis Syndrome Market, by Diagnostic Test (2022-2027) 7.3. Middle East and Africa Piriformis Syndrome Market, by Treatment (2022-2027) 7.4. Middle East and Africa Piriformis Syndrome Market, by Distribution Channel (2022-2027) 7.5. Middle East and Africa Piriformis Syndrome Market, by End-User (2022-2027) 7.6. Middle East and Africa Piriformis Syndrome Market, by Country (2022-2027) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8. Latin America Piriformis Syndrome Market (2022-2027) 8.1. Latin America Piriformis Syndrome Market, by Cause (2022-2027) 8.2. Latin America Piriformis Syndrome Market, by Diagnostic Test (2022-2027) 8.3. Latin America Piriformis Syndrome Market, by Treatment (2022-2027) 8.4. Latin America Piriformis Syndrome Market, by Distribution Channel (2022-2027) 8.5. Latin America Piriformis Syndrome Market, by End-User (2022-2027) 8.6. Latin America Piriformis Syndrome Market, by Country (2022-2027) • Brazil • Argentina • Rest Of Latin America 9. European Piriformis Syndrome Market (2022-2027) 9.1. European Piriformis Syndrome Market, by Cause (2022-2027) 9.2. European Piriformis Syndrome Market, by Diagnostic Test (2022-2027) 9.3. European Piriformis Syndrome Market, by Treatment (2022-2027) 9.4. European Piriformis Syndrome Market, by Distribution Channel (2022-2027) 9.5. European Piriformis Syndrome Market, by End-User (2022-2027) 9.6. European Piriformis Syndrome Market, by Country (2022-2027) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 10. Company Profile: Key players 10.1. Bayer AG 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Novartis AG 10.3. AstraZeneca 10.4. Endo Pharmaceuticals 10.5. Teva Pharmaceuticals 10.6. Omron Healthcare 10.7. Sanofi S.A. 10.8. DePuy Synthes Companies 10.9. Miracle Stretch, LLC 10.10. Flex Pharma, Inc. 10.11. Nidd valley medical 10.12. SEIRIN Corporation 10.13. Others

About This Report

Report ID 70140
Category Healthcare
Published Date Auguet2020
Updated Date March 2022
Contact Us